Bionomics
(NASDAQ) BNOX
Bionomics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$662.72K
Net Income (TTM)
$374.93M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
BNOX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bionomics
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Spyridon Papapetropoulos, MD, PhD
Website
www.neuphoriatx.comHeadquarters
Eastwood, SA 5063, AU
BNOX Financials
Key Financial Metrics (TTM)
Gross Margin
96%
Operating Margin
-137%
Net Income Margin
-45%
Return on Equity
-15%
Return on Capital
-33%
Return on Assets
-10%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$1.13B
EBITDA
$1.13B
Operating Cash Flow
$77.23M
Capital Expenditure
$0.00
Free Cash Flow
$77.23M
Cash & ST Invst.
$14.21B
Total Debt
$116.31M
Bionomics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
8
N/A
Net Income
$1.86M
+195.9%
EBITDA
$4.06M
-25.7%
Quarterly Fundamentals
Net Cash
$22.17M
+434.8%
Accounts Receivable
$1.11M
+3021.1%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-10.20%
N/A
Return on Invested Capital
-33.11%
N/A
Free Cash Flow
$6.44M
-91.7%
Operating Cash Flow
$6.44M
-91.7%